Show Notes
Xaira Therapeutics is harnessing AI to fundamentally change how we discover and develop medicines, shortening the path from lab to clinic for previously "un-druggable" targets. Dr. Marc Tessier-Lavigne, co-founder, chairman, and CEO of Xaira Therapeutics, sits down with Sonia Gupta, co-head of Biotech Investment Banking at Goldman Sachs, to explore his journey from neuroscience to higher-education, the critical role of talent and purpose in building world-class organizations, and a roadmap for translating scientific insight into real-world impact. This session was recorded at the 2025 Goldman Sachs Builders and Innovators Summit on October 16, 2025.
The opinions and views expressed herein are as of the date of publication, subject to change without notice, and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only, and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates, is used here strictly for informational and identification purposes only and is not used to imply any ownership or license rights between any such company and Goldman Sachs.
A transcript is provided for convenience and may differ from the original video or audio content. Goldman Sachs is not responsible for any errors in the transcript. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs.
Disclosures applicable to research with respect to issuers, if any, mentioned herein are available through your Goldman Sachs representative or at http://www.gs.com/research/hedge.html
Goldman Sachs does not endorse any candidate or any political party.
Copyright 2026, Goldman Sachs, all rights reserved.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More from Talks at GS
OpenEvidence is working to rapidly advance clinical decision-making, emerging as a global leader in delivering gold-standard medical knowledge to physicians at the point of care. Daniel Nadler, co-founder and CEO of OpenEvidence, joins Meena Flynn, chair of Global Private Wealth Management and co-head of One Goldman Sachs, to discuss OpenEvidence's founding story, how the platform acts as a “brain extender” for doctors, and the future of matching patients with life-saving clinical trials.
U.S. Soccer has entered a transformative era, driving the growth of the sport across the nation as it capitalizes on hosting the 2026 World Cup and other global sporting tournaments to come. JT Batson, CEO and secretary general of U.S. Soccer, joins Dave Dase, head of Goldman Sachs' global sports business, to discuss the legacy of the World Cup, U.S. Soccer’s strategic plans through the 2028 Los Angeles Olympics and the 2031 Women’s World Cup, and how an invigorated grassroots culture could make the U.S. "one of the world's great soccer countries."
The luxury real estate brokerage SERHANT. generates over $1 billion in transactions every month. On Talks at GS, Ryan Serhant, founder and CEO of SERHANT., joins Tucker York, chair of Goldman Sachs global Wealth Management, to discuss his transition from the theatre to real estate during the 2008 financial crisis, his video-led sales strategies, and how calculated risks have led to the company’s success.
WellWithAll is a purpose-led health and wellness company built on an inclusive capitalism model that reinvests 20% of its profits into health equity initiatives to help close the wellness gap across generations. Demond Martin, co-founder and CEO of WellWithAll, joins Kim Posnett, global co-head of Investment Banking at Goldman Sachs, to discuss his transition from a 21-year career on Wall Street to becoming a founder, and how his philosophy of building deep, value-aligned relationships—as described in his book Friends of the Good—has shaped his approach to mentorship and leading a mission-driven business.
The NobleReach Foundation taps into leaders across sectors – technology, science, government, academia – who have a penchant for national service and a desire to bridge the gap between a flourishing private sector career and large-scale public problem-solving. Arun Gupta, NobleReach’s CEO, joins John Mallory, co-head of Wealth Management at Goldman Sachs, to describe careers that are rich in "hidden capital"—trust, learning, and mission—and that align personal ambition with civic responsibility amid rapid AI disruption and geopolitical change.